1 янв. 2024 г. · Patients receiving PRO devices had higher rates of 1-year disabling stroke (KM estimates 2.6% vs 0.4%; log-rank p=0.001), predominantly ...

16 мая 2023 г. · In this review, we discuss mid- to long-term clinical outcomes and long-term durability data of TAVI from landmark clinical trials compared to surgical ...

7 февр. 2024 г. · After 10 years, 98.9% of patients could be followed up (2 TAVI and 1 SAVR patients were lost) and of these 101 (36.1%) patients were alive.

19 нояб. 2023 г. · Learn more about TAVI outcomes with this session: examine the impact of high-gradient and discordant low-gradient aortic stenosis, ...

3 нояб. 2023 г. · Conversely, repeat TAVI showed better early outcomes (30-day mortality 2–5%) than surgical explantation. However, the longer-term outcomes, ...

In this article, we provide a brief overview of the past, current and newer devices for transfemoral (TF) TAVI and their post-procedural outcomes.

Using the Edwards Sapien system, the Partner Study demonstrated a similar mortality rate to surgery at 30 days (3.4% vs 6.5%; P = .07) and at 1 year (24.2% vs ...

Thirty-day outcomes were MACE (4.3%), cardiovascular death (2.1%), all-cause death (2.6%), stroke (2.1%), disabling stroke (1.3%), VC (7.2%), major VC (1.7%), ...

6 мая 2024 г. · Witberg noted that 40% of patients in their analysis had no improvement in LV function after TAVI. One gap in the data is how patients with ...

In this systematic review and meta-analysis, we found that emergency/urgent TAVIs had a significantly higher rate of AKI, hemodialysis, and mortality. This is ...